Pelthos Therapeutics (PTHS) Net Margin (2025 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Net Margin of 131.29% for Q4 2025, up 97.62% quarter-over-quarter from 5523.13% in Q3 2025.
Pelthos Therapeutics (PTHS) Net Margin (2025 - 2026) Analysis & Trends
Pelthos Therapeutics' Net Margin history runs 1 years deep, the most recent figure standing at 131.29% for Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 12.74% |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | -16.51% |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -3.12% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 12.09% |
| 10 | Pelthos Therapeutics | 93.05 Mn | 68.49 Mn | 21.23 Mn | -182.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -182.92% |
| Dec 31, 2025 | -131.29% |
| Sep 30, 2025 | -5,523.13% |